尿酸介导OPRD1基因低甲基化影响阿尔茨海默病
PDF下载 (120)陈 瑶,陈 勇,应 颖,范剑波,耿保庆,郑成应,徐 婷,傅浩源,张韵格,陈 吉.尿酸介导OPRD1基因低甲基化影响阿尔茨海默病[J].宁波大学学报(理工版),2023,36(4):78-88.DOI:10.20098/j.cnki.1001-5132.2023.0414
CHEN Yao,CHEN Yong,YING Ying,FAN Jianbo,GENG Baoqing,ZHENG Chengying,XU Ting,FU Haoyuan,ZHANG Yunge,CHEN Ji.Uric acid mediated hypomethylation of OPRD1 gene affects Alzheimer’s disease[J].Journal of Ningbo University(Natural Science & Engineering Edition),2023,36(4):78-88.DOI:10.20098/j.cnki.1001-5132.2023.0414
| Title: | Uric acid mediated hypomethylation of OPRD1 gene affects Alzheimer’s disease |
| 作者: | 陈 瑶, 陈 勇, 应 颖, 范剑波, 耿保庆, 郑成应, 徐 婷, 傅浩源, 张韵格, 陈 吉 |
| Author(s): | CHEN Yao, CHEN Yong, YING Ying, FAN Jianbo, GENG Baoqing, ZHENG Chengying, XU Ting, FU Haoyuan, ZHANG Yunge, CHEN Ji |
| 关键词: | 尿酸; 关键酶; OPRD1基因; 甲基化; 阿尔茨海默病; Alzheimer’s disease |
| Keywords: | uric acid; key enzymes; OPRD1 gene; methylation |
| 分类号: | R741 |
| DOI: | 10.20098/j.cnki.1001-5132.2023.0414 |
| 文献标识码: | A |
| 摘要: | 探讨OPRD1基因甲基化与尿酸及阿尔茨海默病的相关性, 并在细胞实验中证实尿酸可影响OPRD1基因甲基化水平. 采集阿尔茨海默病组、高尿酸血症组及健康对照组的静脉血, 检测OPRD1基因甲基化水平, 并探讨与尿酸水平的相关性. 细胞实验中, 采用不同尿酸浓度先后处理细胞, 分别检测OPRD1基因甲基化水平. 结果表明, 高尿酸血症组OPRD1基因pos2、pos4位点甲基化水平低于健康对照组, 阿尔茨海默病组pos4位点甲基化水平高于健康对照组, 尿酸水平与OPRD1基因甲基化水平负相关, 高浓度尿酸下细胞OPRD1基因pos2、pos3、pos4位点的甲基化水平更低. 由此得出尿酸可能通过介导OPRD1基因pos4位点的低甲基化修饰, 从而影响阿尔茨海默病的发病. |
| Abstract: | The present study was aimed to investigate the correlation between OPRD1 gene methylation, uric acid and Alzheimer’s disease. It was also examined whether uric acid could affect OPRD1 gene methylation in vitro. The venous blood of the patients with Alzheimer’s disease, the hyperuricemia group and the healthy control group was collected. The cells were successively treated with different concentrations of uric acid and the methylation level of OPRD1 gene was subsequently determined. The methylation levels of OPRD1 at pos2 and pos4 in the hyperuricemia group were lower than those of the healthy control group; while the methylation level of pos4 in the Alzheimer’s disease group was higher than that of the healthy control group. Uric acid levels were negatively correlated with OPRD1 gene methylation levels. In vitro, the methylation levels at pos2, pos3 and pos4 sites of OPRD1 gene in cells with high concentration of uric acid were lower even further. The present study suggested that uric acid may affect the onset of Alzheimer’s disease by mediating the hypomethylation modification at the pos4 site of OPRD1 gene. |
| 参考文献 /References: | [1] Ji H, Wang Y, Liu G, et al. Elevated OPRD1 promoter methylation in Alzheimer’s disease patients[J]. PLoS One, 2017, 12(3):e0172335. [2] Jansen K, Faull R, Dragunow M, et al. Alzheimer’s disease: Changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors — An autoradiographic study[J]. Neuroscience, 1990, 39(3):613-627. [3] Roussotte F, Jahanshad N, Hibar D, et al. A commonly carried genetic variant in the delta opioid receptor gene, OPRD1, is associated with smaller regional brain volumes: Replication in elderly and young populations[J]. Human Brain Mapping, 2014, 35(4):1226-1236. [4] Du N, Xu D, Hou X, et al. Inverse association between serum uric acid levels and Alzheimer’s disease risk[J]. Molecular Neurobiology, 2016, 53(4):2594-2599. [5] Ye B, Lee W, Ham J, et al. Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer’s disease biomarker related cognitive decline?[J]. European Journal of Neurology, 2016, 23(5):948-957. [6] Chen Y, Li X K, Ying Y, et al. Preliminary study on deoxyribonucleic acid methylation of breast cancer anti-resistance 1, phospho-diesterase 1C, opioid receptor delta 1 and neurexin 1 in gout and hyperuricemia[J]. Chinese Journal of Rheumatology, 2020, 24(10):676-680. (in Chinese) [7] Gujar H, Weisenberger D, Liang G. The roles of human DNA methyltransferases and rheir isoforms in shaping the epigenome[J]. Genes, 2019, 10(2):172. [8] Schuermann D, Weber A, Sch?r P. Active DNA demethy- lation by DNA repair: Facts and uncertainties[J]. DNA Repair, 2016, 44:92-102. [9] Coppieters N, Dieriks B, Lill C, et al. Global changes in DNA methylation and hydroxymethylation in Alzheimer’s disease human brain[J]. Neurobiology of Aging, 2014, 35(6):1334-1344. [10] Iwata A, Nagata K, Hatsuta H, et al. Altered CpG methylation in sporadic Alzheimer’s disease is associated with APP and MAPT dysregulation[J]. Human Molecular Genetics, 2014, 23(3):648-656. [11] Nicolia V, Fuso A, Cavallaro R, et al. B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A[J]. Journal of Alzheimer’s Disease, 2010, 19(3):895-907. [12] Zhao Y, Zhao B. Oxidative stress and the pathogenesis of Alzheimer’s disease[J]. Oxidative Medicine and Cellular Longevity, 2013, 2013:316523. [13] Turk P, Laayoun A, Smith S, et al. DNA adduct 8- hydroxyl-2’-deoxyguanosine (8-hydroxyguanine) affects function of human DNA methyltransferase[J]. Carcino- genesis, 1995, 16(5):1253-1255. [14] Wang Y, Xu S, Cao Y, et al. Folate deficiency exacerbates apoptosis by inducing hypomethylation and resultant overexpression of DR4 together with altering DNMTs in Alzheimer’s disease[J]. International Journal of Clinical and Experimental Medicine, 2014, 7(8):1945-1957. [15] Mcgeer P, Akiyama H, Itagaki S, et al. Immune system response in Alzheimer’s disease[J]. The Canadian Journal of Neurological Sciences, 1989, 16:516-527. [16] Nicolia V, Cavallaro R, López-González I, et al. DNA methylation profiles of selected pro-inflammatory cytokines in Alzheimer disease[J]. Journal of Neuropa- thology and Experimental Neurology, 2017, 76(1):27-31. [17] Karlsson I, Ploner A, Wang Y, et al. Apolipoprotein E DNA methylation and late-life disease[J]. International Journal of Epidemiology, 2018, 47(3):899-907. [18] Cai Z, Ratka A. Opioid system and Alzheimer’s disease[J]. Neuromolecular Medicine, 2012, 14(2):91-111. [19] Pradhan A, Befort K, Nozaki C, et al. The delta opioid receptor: An evolving target for the treatment of brain disorders[J]. Trends in Pharmacological Sciences, 2011, 32(10):581-590. [20] Thathiah A, De Strooper B. The role of G protein-coupled receptors in the pathology of Alzheimer’s disease[J]. Nature Reviews Neuroscience, 2011, 12(2):73-87. [21] Liu G, Ji H, Liu J, et al. Association of OPRK1 and OPRM1 methylation with mild cognitive impairment in Xinjiang Han and Uygur populations[J]. Neuroscience Letters, 2017, 636:170-176. [22] Ji H, Wang Y, Liu G, et al. OPRK1 promoter hypermethylation increases the risk of Alzheimer’s disease[J]. Neuroscience Letters, 2015, 606:24-29. [23] Sheng S, Huang J, Ren Y, et al. Neuroprotection against hypoxic/ischemic injury: δ-opioid receptors and BDNF- TrkB pathway[J]. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 2018, 47(1):302-315. [24] He X, Sandhu H, Yang Y, et al. Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/ molecular events[J]. Cellular and Molecular Life Sciences, 2013, 70(13):2291-2303. [25] Chao D, Bazzy-Asaad A, Balboni G, et al. Activation of DOR attenuates anoxic K+ derangement via inhibition of Na+ entry in mouse cortex[J]. Cerebral Cortex, 2008, 18(9):2217-2227. [26] Zhang J, Haddad G, Xia Y. Delta-, but not mu- and kappa-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury[J]. Brain Research, 2000, 885(2):143-153. [27] Yang Y, Xia X, Zhang Y, et al. Delta-opioid receptor activation attenuates oxidative injury in the ischemic rat brain[J]. BMC Biology, 2009, 7:55. [28] Tian X, Hua F, Sandhu H, et al. Effect of δ-opioid receptor activation on BDNF-TrkB vs. TNF-α in the mouse cortex exposed to prolonged hypoxia[J]. International Journal of Molecular Sciences, 2013, 14(8):15959-15976. [29] Euser S, Hofman A, Westendorp R, et al. Serum uric acid and cognitive function and dementia[J]. Brain, 2009, 132:377-382. [30] Wang T, Wu Y, Sun Y, et al. A Prospective study on the association between uric acid and cognitive function among middle-aged and older Chinese[J]. Journal of Alzheimer’s Disease, 2017, 58(1):79-86. [31] Khan A, Quinn T, Hewitt J, et al. Serum uric acid level and association with cognitive impairment and dementia: Systematic review and meta-analysis[J]. AGE, 2016, 38(1):16. |
| 备注/Memo: | 收稿日期: 2023－04－13. 宁波大学学报（理工版）网址: http://journallg.nbu.edu.cn/基金项目: 浙江省医学科学研究基金（2020KY328, 2020KY268）.第一作者: 陈瑶（1997－）, 女, 浙江台州人, 硕士/住院医师, 主要研究方向: 风湿免疫. E-mail: cheny10290@enzemed.com*通信作者: 陈勇（1968－）, 男, 浙江宁波人, 主任医师, 主要研究方向: 风湿免疫. E-mail: nbdeyycy@163.com 宁波大学学报（理工版）网址：http://journallg.nbu.edu.cn/ |
